Loading clinical trials...
Loading clinical trials...
The purpose of this clinical research study is to determine whether apixaban will be safe in people who have recently had unstable angina or a heart attack.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
NCT07436429 · Myocardial Infarction (MI), ST-Elevation Myocardial Infarction, and more
NCT06365502 · Acute Coronary Syndrome (ACS)
NCT07424482 · Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), Anxiety, and more
NCT07374718 · Acute Coronary Syndrome (ACS), High Bleeding Risk(HBR), and more
NCT01944800 · Acute Coronary Syndrome (ACS)
Scottsdale Cardiovasular Research Institute
Scottsdale, Arizona
Los Angeles County & University Of Southern Ca. Medical Cen.
Los Angeles, California
Radiant Research,Santa Rosa
Santa Rosa, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions